These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 19884484)

  • 1. Dementia diagnostics 2.0--transfer from research studies into routine clinical practice.
    Otto M
    Clin Chem; 2010 Feb; 56(2):152-3. PubMed ID: 19884484
    [No Abstract]   [Full Text] [Related]  

  • 2. The utility of the new research diagnostic criteria for Alzheimer's disease.
    Dubois B; Gauthier S; Cummings J
    Int Psychogeriatr; 2013 Feb; 25(2):175-7. PubMed ID: 23148941
    [No Abstract]   [Full Text] [Related]  

  • 3. [Amyloid and tau imaging, its present and future].
    Okamura N; Harada R; Kudo Y; Yanai K
    Nihon Yakurigaku Zasshi; 2015 Sep; 146(3):144-9. PubMed ID: 26354014
    [No Abstract]   [Full Text] [Related]  

  • 4. Analytical challenges related to the use of biomarker ratios for the biological diagnosis of Alzheimer's disease.
    Lehmann S; Delaby C; Paquet C; Gabelle A
    Clin Chem Lab Med; 2015 Jul; 53(8):e175-7. PubMed ID: 25870963
    [No Abstract]   [Full Text] [Related]  

  • 5. [Biomarker and imaging of Alzheimer's disease].
    Kawarabayashi T; Shoji M
    No To Shinkei; 2005 Oct; 57(10):839-52. PubMed ID: 16277229
    [No Abstract]   [Full Text] [Related]  

  • 6. Biomarkers reflecting different facets of Alzheimer's disease.
    Zetterberg H
    Eur J Neurol; 2008 Nov; 15(11):1143-4. PubMed ID: 18973609
    [No Abstract]   [Full Text] [Related]  

  • 7. International quality control survey of neurochemical dementia diagnostics.
    Lewczuk P; Beck G; Ganslandt O; Esselmann H; Deisenhammer F; Regeniter A; Petereit HF; Tumani H; Gerritzen A; Oschmann P; Schröder J; Schönknecht P; Zimmermann K; Hampel H; Bürger K; Otto M; Haustein S; Herzog K; Dannenberg R; Wurster U; Bibl M; Maler JM; Reubach U; Kornhuber J; Wiltfang J
    Neurosci Lett; 2006 Nov; 409(1):1-4. PubMed ID: 17045397
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recommendations for the incorporation of biomarkers into Alzheimer clinical trials: an overview.
    Morris JC; Selkoe DJ
    Neurobiol Aging; 2011 Dec; 32 Suppl 1():S1-3. PubMed ID: 22078168
    [No Abstract]   [Full Text] [Related]  

  • 9. Amyloid β (Aβ) and phospho-tau (p-tau) as diagnostic biomarkers in Alzheimer's disease.
    Prvulovic D; Hampel H
    Clin Chem Lab Med; 2011 Mar; 49(3):367-74. PubMed ID: 21342022
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Will CSF analysis become routine in people with memory complaints?
    Gauthier S
    Lancet Neurol; 2009 Jul; 8(7):595-6. PubMed ID: 19523878
    [No Abstract]   [Full Text] [Related]  

  • 11. Cerebrospinal fluid in the dementias.
    Zetterberg H; Rohrer JD; Schott JM
    Handb Clin Neurol; 2017; 146():85-97. PubMed ID: 29110781
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular markers of Alzheimer disease early diagnostic: investigation perspectives of peripheral tissues.].
    Paltsev MA; Zuev VA; Kozhevnikova EO; Linkova NS; Kvetnaia TV; Polyakova VO; Kvetnoy IM
    Adv Gerontol; 2017; 30(6):809-817. PubMed ID: 29608821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Biomarker of dementia: clinical and preclinical diagnosis].
    Shoji M
    Nihon Rinsho; 2012 May; 70(5):857-63. PubMed ID: 22620013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Methods for analysis of amyloid-β aggregates.
    Bruggink KA; Müller M; Kuiperij HB; Verbeek MM
    J Alzheimers Dis; 2012; 28(4):735-58. PubMed ID: 22156047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neurochemical dementia diagnostics for Alzheimer's disease and other dementias: an ISO 15189 perspective.
    Waedt J; Kleinow M; Kornhuber J; Lewczuk P
    Biomark Med; 2012 Oct; 6(5):685-90. PubMed ID: 23075248
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Development of a High-Sensitivity Method for the Measurement of Human Nasal Aβ42, Tau, and Phosphorylated Tau.
    Liu Z; Kameshima N; Nanjo T; Shiino A; Kato T; Shimizu S; Shimizu T; Tanaka S; Miura K; Tooyama I
    J Alzheimers Dis; 2018; 62(2):737-744. PubMed ID: 29480194
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of cerebrospinal fluid biomarkers in diagnosis of dementia across Europe.
    Hort J; Bartos A; Pirttilä T; Scheltens P
    Eur J Neurol; 2010 Jan; 17(1):90-6. PubMed ID: 19659752
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 18F-barbiturates are PET tracers with diagnostic potential in Alzheimer's disease.
    Calamai E; Dall'Angelo S; Koss D; Domarkas J; McCarthy TJ; Mingarelli M; Riedel G; Schweiger LF; Welch A; Platt B; Zanda M
    Chem Commun (Camb); 2013 Jan; 49(8):792-4. PubMed ID: 23235438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological markers in Alzheimer's disease.
    Grundke-Iqbal I; Rolkova G; Konstekova E; Iqbal K
    Bratisl Lek Listy; 2006; 107(9-10):359-65. PubMed ID: 17262988
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel D-A-D based near-infrared probes for the detection of β-amyloid and Tau fibrils in Alzheimer's disease.
    Li Y; Wang K; Zhou K; Guo W; Dai B; Liang Y; Dai J; Cui M
    Chem Commun (Camb); 2018 Aug; 54(63):8717-8720. PubMed ID: 30023996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.